Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,143,306 shares of the biotechnology company’s stock after purchasing an additional 212,401 shares during the period. Vanguard Group Inc. owned about 10.79% of Axon Enterprise worth $2,547,878,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. ICA Group Wealth Management LLC purchased a new stake in Axon Enterprise during the fourth quarter worth $26,000. Trivant Custom Portfolio Group LLC purchased a new stake in shares of Axon Enterprise during the 1st quarter worth about $31,000. BKM Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $32,000. First PREMIER Bank purchased a new position in shares of Axon Enterprise in the 1st quarter valued at about $33,000. Finally, Key Financial Inc raised its holdings in Axon Enterprise by 367.6% in the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, Director Jeri Williams sold 308 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total transaction of $95,501.56. Following the completion of the sale, the director now directly owns 1,607 shares of the company’s stock, valued at approximately $498,282.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Jeri Williams sold 308 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, President Joshua Isner sold 44,000 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the completion of the sale, the president now owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock valued at $27,684,677 in the last quarter. Insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of several research analyst reports. JMP Securities reaffirmed a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research note on Tuesday, May 7th. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Tuesday, May 7th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Finally, Morgan Stanley increased their target price on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $342.54.

Axon Enterprise Trading Up 0.9 %

Shares of AXON traded up $2.78 during mid-day trading on Friday, reaching $308.45. The stock had a trading volume of 269,770 shares, compared to its average volume of 477,359. Axon Enterprise, Inc. has a 52-week low of $175.37 and a 52-week high of $329.87. The firm has a market cap of $23.28 billion, a price-to-earnings ratio of 90.19, a P/E/G ratio of 6.95 and a beta of 0.95. The business’s fifty day moving average is $292.47 and its 200 day moving average is $289.69. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. The business had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The business’s revenue for the quarter was up 34.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.51 EPS. On average, sell-side analysts predict that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.